Skip to main content
OpenTrials

Clinical trial condition

TDP-43 Proteinopathies

Explore clinical trials studying TDP-43 Proteinopathies. Study availability and eligibility vary by location and protocol.

870 public trials 211 recruiting studies
Refine in advanced search Browse all conditions

TDP-43 Proteinopathies trial results

Completed

Phase 3 Study of Dexpramipexole in ALS

NCT01281189

Conditions
Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations
  • Barrow Neurological Institute - St. Joseph's Hospital Phoenix, Arizona, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • University of California at San Francisco - Fresno Fresno, California, United States
  • University of California, Irvine Orange, California, United States
View all 82 locations
View Trial Details
Completed

Advancing Research and Treatment for Frontotemporal Lobar Degeneration (ARTFL)

NCT02365922

Conditions
Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS), Aphasia, +51 more
Locations
  • University of Alabama Birmingham, Alabama, United States
  • University of California, Los Angeles Los Angeles, California, United States
  • University of California, San Diego San Diego, California, United States
  • University of California, San Francisco San Francisco, California, United States
View all 17 locations
View Trial Details

Related conditions